RSS Feed
Search Ask-Cato.com
Tags
510(k) adverse events ANDA biologics biomarkers biosimilar biotech BLA cancer Cato BioVentures Cato Research CDER CDRH clinical investigator clinical research clinical trials CMC conference CROs drug development eCTD efficacy FDA funding GlobalSubmit guidance IND in vitro diagnostics labeling manufacturing marketing application medical devices NDA nonclinical research oncology Orphan Drug Designations pediatric PMA postmarketing protocol safety statistical analysis transparency venture capital webinarCategories
- Clinical Trials (70)
- Conferences and Meetings (36)
- eCTD (30)
- FDA (109)
- Guest Posts (5)
- Health Canada (7)
- Industry News (87)
- Project Management (1)
- Publications (7)
- Regulatory Strategy (57)
- Social Media (7)
- Statistics (9)
- Uncategorized (1)
- Venture Capital (11)
- Webinars (26)
Tag Archives: BIO 2010
Important Steps Forward for Early Detection and Diagnose of Alzheimer’s Disease
Image via Wikipedia In a recent report by Geert De Meyer of Ghent University in Belgium and colleagues, titled “Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People” (Arch Neurol. 2010;67(8):949-956) it was demonstrated that measuring certain proteins in … Continue reading
Posted in Clinical Trials, Conferences and Meetings, Industry News, Publications
Tagged Alzheimer’s Disease, BIO 2010, biomarker, clinical trials, drug development, personalized medicine
Comments Off
Cato at BIO 2010
The BIO International Convention is the largest global event for the biotechnology industry. It attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry. This year’s … Continue reading
Posted in Conferences and Meetings
Tagged BIO, BIO 2010, biotech, Cato BioVentures, Cato Research, Chicago, CROs, Quebec
Comments Off
